Novo Holdings A/S’s Pharvaris PHVS Stock Holding History

Novo Holdings A/S’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.4M	Sell	1,400,000 -350,000	-20%	-$10.6M	2.81%	12
2026 Q1	$49.4M	Hold	1,750,000	–	–	4.01%	10
2025 Q4	$48.6M	Hold	1,750,000	–	–	3.77%	10
2025 Q3	$43.7M	Buy	1,750,000 +25,000	+1%	+$555K	2.81%	12
2025 Q2	$30.4M	Hold	1,725,000	–	–	2.14%	16
2025 Q1	$27.1M	Hold	1,725,000	–	–	2.06%	16
2024 Q4	$33.1M	Hold	1,725,000	–	–	2%	15
2024 Q3	$31.9M	Hold	1,725,000	–	–	1.59%	20
2024 Q2	$32.4M	Buy	1,725,000 +556,970	+48%	+$11.3M	1.75%	17
2024 Q1	$27M	Sell	1,168,030 -371,295	-24%	-$9.86M	1.86%	20
2023 Q4	$43.2M	Buy	1,539,325 +210,000	+16%	+$4.25M	2.67%	13
2023 Q3	$27.7M	Hold	1,329,325	–	–	2.05%	19
2023 Q2	$20.1M	Hold	1,329,325	–	–	1.56%	23
2023 Q1	$10.7M	Buy	1,329,325 +142,018	+12%	+$1.25M	0.71%	37
2022 Q4	$13.4M	Buy	1,187,307 +577,307	+95%	+$3.04M	0.83%	35
2022 Q3	$4.68M	Buy	610,000 +90,661	+17%	+$1.42M	0.22%	47
2022 Q2	$11.5M	Buy	519,339 +3,018	+0.6%	+$56.2K	0.57%	33
2022 Q1	$9.37M	Hold	516,321	–	–	0.49%	36
2021 Q4	$7.43M	Buy	516,321 +97,378	+23%	+$1.52M	0.35%	39
2021 Q3	$7.43M	Buy	418,943 +307,799	+277%	+$5.27M	0.38%	37
2021 Q2	$2.07M	Buy	111,144 +61,144	+122%	+$1.39M	0.09%	52
2021 Q1	$1.4M	Buy	+50,000	New	+$1.57M	0.06%	49

Other funds holding PHVS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Novo Holdings A/S's PHVS Position: Q2 2026 in Review

Novo Holdings A/S reduced its Pharvaris (PHVS) stake by 20% in Q2 2026, selling an estimated $10.6M and leaving 1,400,000 shares worth $48.4M. The position accounts for 2.81% of the portfolio, ranked #12.

Novo Holdings A/S first reported a position in PHVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $49.4M in Q1 2026. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

Novo Holdings A/S held 1,400,000 shares of Pharvaris worth $48.4M as of Q2 2026.
Novo Holdings A/S sold 350,000 Pharvaris shares in Q2 2026, an estimated $10.6M.
Pharvaris made up 2.81% of Novo Holdings A/S's portfolio in Q2 2026, its #12 holding.
Novo Holdings A/S first reported a position in Pharvaris in Q1 2021 and has held it in 22 quarters since.
Novo Holdings A/S's Pharvaris position peaked at $49.4M in Q1 2026.
125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Novo Holdings A/S's 13F filing for Q2 2026, filed 14 Aug 2026.